Exagen Inc (XGN) — Capital Reinvestment Ratio

Latest as of September 2025: 0.09x

Exagen Inc (XGN) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow ($2.94 Million) in capital expenditures ($275.00K). See XGN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.09x

Capex / Operating Cash Flow

Operating Cash Flow

$2.94 Million

USD

Capital Expenditures

$275.00K

USD

Data as of

Sep 2025

Most recent filing

Annual Capital Reinvestment Ratio for Exagen Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Exagen Inc from None to None. For live market cap and broader valuation context, see Exagen Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow